Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.40 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 5/20 | 0.32 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.32 |
| ▸ | BCDIN3D | Q7Z5W3 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK1 | P23458 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30997372 | 0.80 | KCNH3 (0.41) | KCNH3LOXL2TGFBR1 | |
| SCHEMBL30948885 | 0.78 | RXFP1 (0.41) | KCNH3 | |
| SCHEMBL31030118 | 0.77 | HRH4 (0.32) | — | |
| SCHEMBL31030098 | 0.76 | — | — | |
| SCHEMBL30997392 | 0.76 | KCNH3 (0.41) | KCNH3LOXL2TGFBR1TGFBR2BCDIN3D | |
| SCHEMBL30997368 | 0.75 | KCNH3 (0.34) | KCNH3LOXL2 | |
| SCHEMBL31030142 | 0.74 | HRH4 (0.31) | — | |
| SCHEMBL31057896 | 0.72 | SMN1; SMN2 (0.46) | — | |
| SCHEMBL31010594 | 0.72 | TLR7 (0.33) | MAP4K4 | |
| SCHEMBL30980428 | 0.72 | SMN1; SMN2 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4651950-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| WO-2024155842-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2024-07-25 | — | — | WO | disclosed |